NCT01984281

Brief Summary

The purpose of this study is to determine whether a pedometer-based unsupervised exercise program is more effective than a general exercise recommendation to increase lifestyle physical activity in adult patients with asthma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable asthma

Timeline
Completed

Started Nov 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

November 8, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 14, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

February 14, 2017

Status Verified

February 1, 2017

Enrollment Period

2.1 years

First QC Date

November 8, 2013

Last Update Submit

February 13, 2017

Conditions

Keywords

Physical ActivityPedometersQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Lifestyle physical activity

    The lifestyle physical activity will be estimated as the mean number of steps taken in six days using a pedometer (SW200, YAMAX,Tokyo, Japan)

    12 weeks

Secondary Outcomes (5)

  • Exercise capacity

    12 weeks

  • Asthma Health related quality of life

    12 weeks

  • Asthma Control

    12 weeks

  • Depression and anxiety

    12 weeks

  • Asthma exacerbations

    12 weeks

Study Arms (2)

Pedometer-based prescription

EXPERIMENTAL

After baseline assessments, the control group will receive a educational session, regarding important aspects of asthma (symptoms, treatment, exacerbations, triggers, etc) plus a unsupervised exercise prescription (walking, 5 times per week, for at least 30 minutes) and a pedometer-based physical activity prescription, consisting of targets to be achieved (in terms of steps per day).

Behavioral: Pedometer-based physical activity prescription

Control

NO INTERVENTION

After baseline assessments, the control group will receive a educational session, regarding important aspects of asthma (symptoms, treatment, exacerbations, triggers, etc) plus a unsupervised exercise prescription (walking, 5 times per week, for at least 30 minutes).

Interventions

After baseline assessments, both groups will receive a educational session, regarding important aspects of asthma plus a unsupervised exercise prescription (walking, 5 times per week, for at least 30 minutes). Only the experimental group will receive a pedometer-based physical activity prescription, consisting of targets (steps per day) to be achieved. The initial target will be determined based on the average of steps per day assessed during the baseline assessments plus 1000 steps. The targets will be biweekly. Both groups will be contact once a week (by phone) and will be asked to return for asthma control assessments once a month.

Pedometer-based prescription

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Asthma diagnosis for at least 6 months (according to Global Initiative for Asthma criteria)
  • Regular drug therapy (inhaled corticosteroids or inhaled corticosteroids plus long-acting beta-agonists)
  • Clinical stability during the run-in period (3 weeks)

You may not qualify if:

  • Physical activity practice over once a week
  • Disabling musculoskeletal disease
  • Cardiopathy
  • Other lung disease
  • More than 10 pack-years of smoking
  • Pregnancy
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of the Federal University of Juiz de Fora

Juiz de Fora, Minas Gerais, 36036-110, Brazil

Location

MeSH Terms

Conditions

AsthmaMotor Activity

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesBehavior

Study Officials

  • Bruno V Pinheiro, DSc

    Federal University of Juiz de Fora

    STUDY DIRECTOR
  • Cristina M Coelho, MSc

    Federal University of Juiz de Fora

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc

Study Record Dates

First Submitted

November 8, 2013

First Posted

November 14, 2013

Study Start

November 1, 2013

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

February 14, 2017

Record last verified: 2017-02

Locations